Focus
Drug Discovery Investors: Angels and VC Firms
The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.
Strongest in New York, San Francisco and Boston
- 4,683
- Drug Discovery investors
- 239
- Angel investors
- 4,444
- People at VC/PE firms
- 1,313
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
4,683 Drug Discovery investors
Showing 381-400
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
 Francisco Dopazo General Partner at Humboldt Fund | New York, United States | Venture capital | AIFinTech | ||
 Jamie Stiff Advisor - Mars IAF investment committee at MaRS Investment Accelerator Fund | Toronto, Canada | AcceleratorCorporate VC | AIFinTech | ||
 Jimmy Lu Venture Partner at Panacea Capital | San Francisco, United States | Venture capital | AIClimate | ||
 Zeev Zehavi Vice President at Teva Pharmaceuticals | Petah Tikva, Israel | Corporate VC | Healthcare | ||
 Keith Winter Partner at Teal Ventures | San Diego, United States | AcceleratorSyndicate / Angel group | AIClimate | ||
 Dave Chenn Investor at Oceanpine Capital | Private equity | AIClimate | |||
 Hugo Dessaud Co-Founder JAFHT at Sanofi | Marseille, France | Corporate VC | AIHealthcare | ||
 Andrew Harrison CEO & General Partner at S32 | Menlo Park, United States | Corporate VCVenture capital | AIFinTech | ||
 Christian Beck Advisor at Audaz Capital | Indianapolis, United States | Private equitySyndicate / Angel group | AIConsumer | ||
 David Malka Angel investor, tonic addict & dog father at Truffle Capital | San Juan, Puerto Rico | Private equitySyndicate / Angel group | ClimateConsumer | ||
 Dong Jiang Venture Capital Investor at Hillhouse Investment | China | Private equityVenture capital | AIClimate | ||
 Luna Wang Investor at Efung Capital | Hong Kong | Venture capital | Healthcare | ||
 Holly Flanagan Managing Director at Gabriel Investments | Philadelphia, United States | Private equityVenture capital | ClimateCommerce | ||
 Maximilian Moser Vice President at Eqt Life Sciences | London, United Kingdom | Private equityVenture capital | Healthcare | ||
 William Canestaro Better Arguments Ambassador at The Aspen Institute | Seattle, United States | AcceleratorVenture capital | AICommerce | ||
 Pankaj Gupta Angle Investing at LVX | Dehradun, India | Syndicate / Angel groupVenture capital | HealthcareSaaS | ||
 Jim Hansberger Jr. Investor at Morgan Stanley | Atlanta, United States | Corporate VCPrivate equity | FinTechHardware | ||
 Kuo-Yi Lim Co-Founder at Monk's Hill Ventures | Singapore | Corporate VCPrivate equity | AICommerce | ||
 Patricio Pizarro Co-Founder at Trinity Life Sciences | Santiago, Chile | AcceleratorCorporate VC | AIHealthcare | ||
 David Ticzon President Cornell Class of 2018 at Cornell University | San Francisco, United States | Family Office | AIClimate |
Data: RaiseHunt investor dataset · Snapshot 26 September 2026 · How this data is built · Report a correction or request removal